Most Popular
-
1
Dongduk Women’s University halts coeducation talks
-
2
Defense ministry denies special treatment for BTS’ V amid phone use allegations
-
3
Russia sent 'anti-air' missiles to Pyongyang, Yoon's aide says
-
4
OpenAI in talks with Samsung to power AI features, report says
-
5
Two jailed for forcing disabled teens into prostitution
-
6
South Korean military plans to launch new division for future warfare
-
7
Trump picks ex-N. Korea policy official as his principal deputy national security adviser
-
8
Gold bars and cash bundles; authorities confiscate millions from tax dodgers
-
9
Kia EV9 GT marks world debut at LA Motor Show
-
10
Teen smoking, drinking decline, while mental health, dietary habits worsen
Allergan Korea said Thursday that it has named Kim Ji-hyun, who most recently worked as the general manager of Leo Pharma Korea, as its new CEO.
Kim is a sales and management expert who has worked in various fields spanning the pharmaceutical, finance and consumer goods industries, serving executive roles for Gilead Sciences, AstraZeneca, HSBC and Mattel in Korea.
She received her B.A. in mass communications and media studies from Sogang University and a M.S. in integrated marketing communications from Northwestern University.
Kim is a sales and management expert who has worked in various fields spanning the pharmaceutical, finance and consumer goods industries, serving executive roles for Gilead Sciences, AstraZeneca, HSBC and Mattel in Korea.
She received her B.A. in mass communications and media studies from Sogang University and a M.S. in integrated marketing communications from Northwestern University.
Kim Ji-hyun will replace Allergan Korea’s outgoing CEO Kim Eun-young, who has been promoted to oversee as chief Allergan’s offices in nine Asia-Pacific countries — South Korea, Taiwan, Thailand, Hong Kong, Vietnam, Singapore, Indonesia, the Philippines and Malaysia — as of Dec. 13.
By Sohn Ji-young (jys@heraldcorp.com)
